Status:

COMPLETED

Assessment of Platelet Rich Fibrin Efficiency on Healing Delay and on Jawbone Osteochemonecrosis Provoked by Bisphosphonates

Lead Sponsor:

Centre Hospitalier Régional Metz-Thionville

Conditions:

Jawbone Osteochemonecrosis Induced by Bisphosphonates

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The main objective of our study is to assess, after tooth extraction, the efficacity of PRF in the prevention of healing delay and of jawbone osteochemonecrosis induced by bisphosphonates

Detailed Description

Scientific Context Bisphosphonates (BP) work by slowing down bone remodelling. They are used in the management of different types of cancers and for the treatment of osteoporosis. Recent studies warne...

Eligibility Criteria

Inclusion

  • Patient major(male or female)
  • Documented indication at the initial visit at day 0 (JO) for a maximum extraction of 3 teeth.
  • Treatment with nitrogenous or non-nitrogenous BP by intravenous injection or oral administration whichever the reason for this drug prescription:
  • on going BP treatment
  • patient having received a previous treatment with bisphosphonates (irrespective of the duration and withdrawal date of this treatment)
  • Patient having received the specific information letter regarding the study and having signed the clarified consent form.

Exclusion

  • Patient having a maxillary or mandibulary OCN at Day 0(JO)
  • Positive HIV serology at Day 0(for patients belonging to the PRF group)
  • Previous history of maxillo-cervico-facial radiotherapy
  • Patients with estimated survival expectancy shorter than one year
  • Lack of social security cover
  • Inability of the patient to respect the study follow-up
  • Patient having reached his/her majority and under tutelage,trusteeship or protection of the court
  • Patient whose diagnosis could not be revealed to him/her (especially when the patient or their family expressed this wish).

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 21 2017

Estimated Enrollment :

52 Patients enrolled

Trial Details

Trial ID

NCT01526915

Start Date

September 1 2011

End Date

June 21 2017

Last Update

January 2 2020

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Chu de Dijon

Dijon, France, 21033

2

Scm Bally Curien

Maxéville, France, 54320

3

Chr Metz Thionville

Metz, France, 57038

4

Chu de Nancy

Nancy, France, 54035